Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Epidermolysis Bullosa Dystrophica”

78 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 78 results

Testing effectiveness (Phase 2)Study completedNCT04520022
What this trial is testing

Safety and Effectiveness Study of Allogeneic Umbilical Cord Blood-derived Mesenchymal Stem Cell in Patients With RDEB

Who this might be right for
Recessive Dystrophic Epidermolysis Bullosa
Gangnam Severance Hospital 5
Testing effectiveness (Phase 2)Looking for participantsNCT06594393
What this trial is testing

TCP-25 Gel in Patients With Epidermolysis Bullosa, STEP-study

Who this might be right for
Epidermolysis Bullosa (EB)Dystrophic Epidermolysis BullosaJunctional Epidermolysis Bullosa
Xinnate AB 32
Early research (Phase 1)Active Not RecruitingNCT06713434
What this trial is testing

Pilot Study of ELK-003 Eye Drops for Treating Ocular Manifestations of Epidermolysis Bullosa

Who this might be right for
Junctional Epidermolysis BullosaEpidermolysis Bullosa (EB)Dystrophic Epidermolysis Bullosa+1 more
Fundación DEBRA Chile, Niños Piel de Cristal 20
Very early researchActive Not RecruitingNCT04171661
What this trial is testing

Self-Assembled Skin Substitute for the Treatment of Epidermolysis Bullosa

Who this might be right for
Epidermolysis Bullosa Dystrophica
CHU de Quebec-Universite Laval 1
Not applicableLooking for participantsNCT06423573
What this trial is testing

Assess the Incidence of Skin Cancers in Patients With Epidermolysis Bullosa Receiving Filsuvez

Who this might be right for
Epidermolysis Bullosa, DystrophicEpidermolysis Bullosa, Junctional
Amryt Pharma 580
Testing effectiveness (Phase 2)UnknownNCT04153630
What this trial is testing

Safety Study and Preliminary Efficacy of Infusion Haploidentical Mesenchymal Stem Cells Derived From Bone Marrow for Treating Recessive Dystrophic Epidermolysis Bullosa

Who this might be right for
Epidermolysis Bullosa Dystrophica, Recessive
Instituto de Investigación Hospital Universitario La Paz 9
Large-scale testing (Phase 3)Study completedNCT04491604
What this trial is testing

Ph 3 Efficacy and Safety of B-VEC for the Treatment of DEB

Who this might be right for
Dystrophic Epidermolysis BullosaRecessive Dystrophic Epidermolysis BullosaDominant Dystrophic Epidermolysis Bullosa
Krystal Biotech, Inc. 31
Testing effectiveness (Phase 2)Study completedNCT03012191
What this trial is testing

Gentamicin for RDEB

Who this might be right for
Recessive Dystrophic Epidermolysis Bullosa
University of Southern California 6
Testing effectiveness (Phase 2)UnknownNCT02323789
What this trial is testing

Mesenchymal Stromal Cells in Adults With Recessive Dystrophic Epidermolysis Bullosa

Who this might be right for
Recessive Dystrophic Epidermolysis Bullosa
King's College London 10
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07011589
What this trial is testing

Targeting Collagen VII Antibodies in Bullous Diseases Using Efgartigimod IV (VYVGART)

Who this might be right for
Epidermolysis Bullosa (EB)Epidermolysis Bullosa AcquisitaRecessive Dystrophic Epidermolysis Bullosa+1 more
M. Peter Marinkovich 18
Not applicableStudy completedNCT01716169
What this trial is testing

Treatment of Chronic and Non-Chronic Wounds in Patients With Recessive Dystrophic Epidermolysis Bullosa Using Helicoll Collagen Dressings Versus Standard of Care

Who this might be right for
Epidermolysis Bullosa DystrophicaEpidermolysis Bullosa
Stanford University 10
Large-scale testing (Phase 3)Study completedNCT04917874
What this trial is testing

A Long-term Treatment With B-VEC for Dystrophic Epidermolysis Bullosa

Who this might be right for
Dystrophic Epidermolysis BullosaDEB - Dystrophic Epidermolysis BullosaRecessive Dystrophic Epidermolysis Bullosa+1 more
Krystal Biotech, Inc. 47
Testing effectiveness (Phase 2)Looking for participantsNCT07193134
What this trial is testing

GMEB-SASS: A Gene-Modified Skin Substitute for RDEB Treatment

Who this might be right for
RDEBRecessive Dystrophic Epidermolysis BullosaEpidermolysis Bullosa Dystrophica, Recessive
CHU de Quebec-Universite Laval 9
Not applicableLooking for participantsNCT01019148
What this trial is testing

Characteristics of Patients With Recessive Dystrophic Epidermolysis Bullosa

Who this might be right for
Epidermolysis Bullosa Dystrophica
Stanford University 70
Not applicableWithdrawnNCT02004600
What this trial is testing

Pilot Study Evaluating the Efficiency and the Tolerance of the PDT in the Treatment of Epidermal Dysplasia for Patients Affected by Hereditary DEB

Who this might be right for
Dystrophic Epidermolysis Bullosa
Centre Hospitalier Universitaire de Nice
Testing effectiveness (Phase 2)Looking for participantsNCT06731933
What this trial is testing

Impact of COL7A1 Gene Therapy on SCC Recurrence in RDEB Skin

Who this might be right for
Squamous Cell Carcinoma
Stanford University 16
Testing effectiveness (Phase 2)Looking for participantsNCT05157958
What this trial is testing

Study to Evaluate Safety and Efficacy of ALLO-ASC-SHEET in Subjects With Dystrophic Epidermolysis Bullosa

Who this might be right for
Dystrophic Epidermolysis Bullosa
Anterogen Co., Ltd. 6
Not applicableActive Not RecruitingNCT05843994
What this trial is testing

Artificial Intelligence Patient App for RDEB SCCs

Who this might be right for
Epidermolysis Bullosa Dystrophica
Northwestern University 20
Early research (Phase 1)Study completedNCT05378997
What this trial is testing

Safety, Tolerability, and Pharmacokinetics of Ascending Topical Doses of TCP-25 Applied to Epidermal Suction Blister Wounds, Non-Healing Leg Ulcers and Patients With Dystrophic Epidermolysis Bullosa.

Who this might be right for
BlisterWound of SkinEpidermolysis Bullosa+1 more
Xinnate AB 35
Testing effectiveness (Phase 2)Study completedNCT00951964
What this trial is testing

Treatment of Epidermolysis Bullosa Dystrophica by Polyphenon E (Epigallocatechin 3 Gallate)

Who this might be right for
Epidermolysis Bullosa Dystrophica
Centre Hospitalier Universitaire de Nice 18
Load More Results